Update on blepharospasm: report from the BEBRF International Workshop.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18852443.
- Also identified by DOI 10.1212/01.wnl.0000327601.46315.85 and PMC identifier 2676990.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This review updates understanding and research on blepharospasm, a subtype of focal dystonia. Topics covered include clinical aspects, pathology, pathophysiology, animal models, dry eye, photophobia, epidemiology, genetics, and treatment. Blepharospasm should be differentiated from apraxia of eyelid opening. New insights into pathology and pathophysiology are derived from different types of imaging, including magnetic resonance studies. Physiologic studies indicate increased plasticity and trigeminal sensitization. While botulinum neurotoxin injections are the mainstay of therapy, other therapies are on the horizon.
Medical subject headings
- Blepharospasm